Nuvalent Total Other Income Expense Net from 2010 to 2025

NUVL Stock  USD 71.07  1.87  2.56%   
Nuvalent Total Other Income Expense Net yearly trend continues to be quite stable with very little volatility. Total Other Income Expense Net may rise above about 21.4 M this year. From the period between 2010 and 2025, Nuvalent, Total Other Income Expense Net regression line of its data series had sample variance of 83.9 T and sample variance of 83.9 T. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2020-03-31
Previous Quarter
-8 M
Current Value
11.7 M
Quarterly Volatility
M
 
Covid
Check Nuvalent financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvalent's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.1 M, Interest Expense of 40.2 M or Selling General Administrative of 65.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.1. Nuvalent financial statements analysis is a perfect complement when working with Nuvalent Valuation or Volatility modules.
  
Check out the analysis of Nuvalent Correlation against competitors.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.

Latest Nuvalent's Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of Nuvalent over the last few years. It is Nuvalent's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nuvalent's overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Slightly volatile
   Total Other Income Expense Net   
       Timeline  

Nuvalent Total Other Income Expense Net Regression Statistics

Arithmetic Mean3,538,488
Coefficient Of Variation258.93
Mean Deviation6,892,981
Median(1,451,000)
Standard Deviation9,162,084
Sample Variance83.9T
Range24.7M
R-Value0.75
Mean Square Error40T
R-Squared0.56
Significance0.0009
Slope1,434,201
Total Sum of Squares1259.2T

Nuvalent Total Other Income Expense Net History

202521.4 M
202420.4 M
202323.3 M
20224.3 M
2021-521 K
20202.3 M

About Nuvalent Financial Statements

Nuvalent investors utilize fundamental indicators, such as Total Other Income Expense Net, to predict how Nuvalent Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Other Income Expense Net20.4 M21.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:
Check out the analysis of Nuvalent Correlation against competitors.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.93)
Return On Assets
(0.19)
Return On Equity
(0.29)
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.